The wheat berry is the whole kernel of wheat, sometimes cracked or ground and used as a cereal or cooked food, or made into bread.
Prevention Starts in Children
You’ll probably never meet a kid with atherosclerosis. But you probably know more than a few who carry the seeds. Risk factors and risk behaviors that grow cardiovascular disease begin in childhood.
Sending a Get-well Message Made Easy
A new online service at Cleveland Clinic aims to make hospital stays a little bit nicer. Using the new Email a Patient Program, patients’ loved ones can visit the Cleveland Clinic website anytime to write and send a personal message.
Tales From the Heart – Entire Series Online
Each part of this series chronicles the stories of patients who were at Miller Family Heart & Vascular Institute for specialized heart care.
Who’s Who in a White Coat
Cleveland Clinic is a teaching hospital, so in addition to staff doctors there are residents and fellows caring for patients. All are MD doctors. So what’s the difference among them?
The Ultimate Thanksgiving Meal Makeover
To help you celebrate and give thanks for life, we've made over the traditional Thanksgiving meal so you can thoroughly enjoy every bite and still feel confident that you’re making healthy choices.
Inside the Heart and Vascular Institute
Tuesday, November 15th, Dr. Bruce Lytle, chair of the Cleveland Clinic Miller Family Heart & Vascular Institute, spoke with reporters on the "Sound of Ideas." Hear from the reporters who were there to record this special feature - and one of the patients who participated.
Niacin and the Treatment of HDL Cholesterol
The Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyerides: Impact on Global Health (AIM-HIGH) Study results were presented at the American Heart Association's Scientific Sessions this week.
Tales from the Heart
Today is Day 4 of The Plain Dealer's 8-day series “Tales from the Heart: Inside the Cleveland Clinic Heart Center.”
New Atherosclerosis Drug Dazzles
Cleveland Clinic researchers revealed that an investigational drug known as evacetrapib can boost HDL (good) cholesterol and lower LDL (bad) cholesterol far beyond levels achievable by any other medications currently in use. At the highest tested dosage, the levels of HDL more than doubled.
Recent Comments